| Kevin L Jansen, MD | |
|
3702 S State St Ste 107, South Salt Lake, UT 84115-5096 | |
| (801) 288-2634 | |
| (801) 288-1186 |
| Full Name | Kevin L Jansen |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 25 Years |
| Location | 3702 S State St Ste 107, South Salt Lake, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013908995 | NPI | - | NPPES |
| 4828000340001 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 6555293-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc-riverton Llc | Riverton, UT | Dialysis facility |
| Intermountain Medical Center Dialysis Services | Murray, UT | Dialysis facility |
| Intermountain Medical Center | Murray, UT | Hospital |
| St Mark's Hospital | Salt lake city, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Jordan Valley Medical Center | West jordan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Utah Llc | 2769468065 | 25 |
News Archive
House Ways and Means Subcommittee on Health Chair Nancy Johnson (R-Conn.) on Wednesday met with physician groups to discuss legislation that would stop a 5.1% reduction in Medicare physician reimbursements that is scheduled to take effect Jan. 1, 2007, CQ Today reports.
From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.
In a new study, published in the May issue of Elsevier's Experimental Neurology (www.elsevier.com/locate/yexnr), scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
› Verified 6 days ago
| Entity Name | Nephrology Associates Of Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750473948 PECOS PAC ID: 2769468065 Enrollment ID: O20040628000443 |
News Archive
House Ways and Means Subcommittee on Health Chair Nancy Johnson (R-Conn.) on Wednesday met with physician groups to discuss legislation that would stop a 5.1% reduction in Medicare physician reimbursements that is scheduled to take effect Jan. 1, 2007, CQ Today reports.
From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.
In a new study, published in the May issue of Elsevier's Experimental Neurology (www.elsevier.com/locate/yexnr), scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin L Jansen, MD 3702 S State St Ste 107, South Salt Lake, UT 84115-5096 Ph: (801) 288-2634 | Kevin L Jansen, MD 3702 S State St Ste 107, South Salt Lake, UT 84115-5096 Ph: (801) 288-2634 |
News Archive
House Ways and Means Subcommittee on Health Chair Nancy Johnson (R-Conn.) on Wednesday met with physician groups to discuss legislation that would stop a 5.1% reduction in Medicare physician reimbursements that is scheduled to take effect Jan. 1, 2007, CQ Today reports.
From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.
In a new study, published in the May issue of Elsevier's Experimental Neurology (www.elsevier.com/locate/yexnr), scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
› Verified 6 days ago
Dr. Max Parkanzky, DVM, MS, DACVIM Nephrology Medicare: Not Enrolled in Medicare Practice Location: 331 W Bearcat Dr, South Salt Lake, UT 84115 Phone: 385-341-4444 | |
Danyi Zheng, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 | |
Dr. Ruth Merry Indahyung, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 | |
Dr. James Shaffner, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 | |
Arasu Gopinath, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3702 S State St Ste 107, South Salt Lake, UT 84115 Phone: 801-288-2634 Fax: 801-288-1186 |